Novo Nordisk, Akero Therapeutics filed HSR paperwork on Nov. 5
MLex Summary: Novo Nordisk and Akero Therapeutics each filed their respective Hart-Scott-Rodino Act paperwork on Nov. 5, Akero said in a US securities filing. Novo proposed to buy Akero, a clinical-stage...To view the full article, register now.
Already a subscriber? Click here to view full article